Clinical trial
Evaluation of Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Pneumococcal Conjugated Vaccine (Prevnar®) Under the Auspices of the Taipei City Government Vaccination Program
NCT00488371 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Pneumococcal Conjugated Vaccine (Prevnar®) Under the Auspices of the Taipei City Government Vaccination Program
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- April 30, 2007
- Enrollment
- 250
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.